SDG 3. GOOD HEALTH & WELL-BEING DRUG DISCOVERY AbSci

Synthetic Biology Startup Acquires AI Platform To Disrupt The Drug Industry

0x0.jpg

Synthetic biology company AbSci’s recent acquisition of the artificial intelligence platform, Denovium, could help get novel therapeutics to patients more quickly






Read more on Forbes - Business

You may also like

Comments are closed.